In mid-September, we suggested that investors take a closer look at Pfizer, the big ($211 billion market cap) pharmaceutical company. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post AMAT: Applied MaterialsNext PostThe bullish case for gold, silver and bitcoin in the long run You Might Also Like Should You Sync with Synchrony Financial (SYF) May 17, 2022 Southwest Airlines September 24, 2019 Could aerospace suppliers be impacted by Boeing’s woes? October 14, 2024
You Might Also Like Should You Sync with Synchrony Financial (SYF) May 17, 2022 Southwest Airlines September 24, 2019 Could aerospace suppliers be impacted by Boeing’s woes? October 14, 2024
